Peer-influenced content. Sources you trust. No registration required. This is HCN.

ReachMDShifting Paradigms for Assessment and Management of Lower-Risk Myelodysplastic Syndromes: Genomics, Risk Stratification, and Novel Therapies

In this video-supported CME activity, an expert faculty panel will provide their perspectives and insights on the latest trends and emerging research in low-risk MDS, including guideline-directed diagnostic workup, RS evaluation and SF3B1 testing and their implications, currently approved and novel emerging treatment strategies for managing lower risk MDS, and strategies to mitigate and manage treatment-related adverse events.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form